Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Incidence of adverse events (AEs) reported in the 2 groups during 24 weeks of treatment
| Placebo (n = 80) | Evogliptin (n = 78) | |
|---|---|---|
| Number of patients with AEs, n (%) | 28 (35.0) | 26 (33.3) |
| Drug‐related AEs, n (%) | 0 (0.0) | 4 (5.1) |
| Serious AEs, n (%) | 1 (1.3) | 0 (0.0) |
| Drug‐related serious AEs, n (%) | 0 (0.0) | 0 (0.0) |
| AEs reported in ≥ 3% | ||
| Nasopharyngitis, n (%) | 5 (6.3) | 5 (6.4) |
| Arthralgia, n (%) | 0 (0.0) | 3 (3.8) |
| Gastrointestinal disorders, n (%) | 7 (8.8) | 4 (5.1) |
